Page last updated: 2024-11-05

xylazine and Acquired Immune Deficiency Syndrome

xylazine has been researched along with Acquired Immune Deficiency Syndrome in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez, N1
Vargas Vidot, J1
Panelli, J1
Colón, H1
Ritchie, B1
Yamamura, Y1

Other Studies

1 other study available for xylazine and Acquired Immune Deficiency Syndrome

ArticleYear
GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles.
    Drug and alcohol dependence, 2008, Aug-01, Volume: 96, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adrenergic alpha-Agonists; Adult; Female; Gas Chroma

2008